Alnylam Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$292.58(as of Jun 3, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Alnylam Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$292.58
Ticker SymbolALNY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees2,500
CountyUSA
Market Cap$38,200.6M
EBIDTA806.9M
10-Day Moving Average296.89
P/E Ratio70.06
20-Day Moving Average294.61
Forward P/E Ratio31.65
50-Day Moving Average307.82
Earnings per Share3.98
200-Day Moving Average383.39
Profit Margin17.65%
RSI45.19
Shares Outstanding133.5M
ATR10.01
52-Week High495.55
Volume986,965
52-Week Low284.28
Book Value1,075.4M
P/B Ratio37.61
Upper Keltner317.14
P/S Ratio9.43
Lower Keltner272.08
Debt-to-Equity Ratio317.14
Next Earnings Date07/29/2026
Cash Surplus361.3M
Next Ex-Dividend DateUnknown
This innovative biotech stock has helped transform RNAi into an innovative new class of medicine. You have probably heard about RNA and mRNA innovation as the basis for the COVID-19 vaccine. This novel technology is set to shake up the medical world, and Alnylam is well-positioned to benefit from it.
Alnylam Pharmaceuticals Inc In Our Stock Scanner
As of Jun 04, 2026
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Piercing PatternScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Blue Chip Stocks at 52-Week LowScan Type: Stock Fundamentals
As of ---
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.